Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY10 | O00398 | 4/20 | 0.52 |
| ▸ | GPR174 | Q9BXC1 | 4/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.47 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.46 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.46 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | NAPEPLD | Q6IQ20 | 1/20 | 0.44 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.44 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.44 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22032619 | 0.94 | LPAR3 (0.55) | P2RY10GPR174LPAR3LPAR1ENPP2 | |
| SCHEMBL6233994 | 0.94 | LPAR3 (0.55) | P2RY10GPR174LPAR3LPAR1ENPP2 | |
| SCHEMBL6239255 | 0.94 | LPAR3 (0.55) | P2RY10GPR174LPAR3LPAR1ENPP2 | |
| SCHEMBL10329406 | 0.87 | FAAH (0.54) | LPAR1FAAH | |
| SCHEMBL16561864 | 0.85 | FAAH (0.47) | PLA2G2CFAAH | |
| SCHEMBL16561876 | 0.85 | FAAH (0.47) | PLA2G2CFAAH | |
| SCHEMBL17707881 | 0.85 | FAAH (0.51) | LPAR1FAAH | |
| SCHEMBL12572453 | 0.84 | FAAH (0.46) | PLA2G2CFAAH | |
| SCHEMBL14287850 | 0.84 | FAAH (0.46) | PLA2G2CFAAH | |
| SCHEMBL19068549 | 0.84 | P2RY10 (0.54) | P2RY10GPR174LPAR3PLA2G2CLPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170265476-A1 | ANTIMICROBIAL COMPOSITION | Safehands Solutions, LLC | 2017-09-21 | — | — | US | disclosed |
| US-9693564-B2 | Water based antimicrobial composition using benzalkonium chloride and cocamidopropyl PG-dimonium chloride phosphate | Safehands Solutions, LLC (US) | 2017-07-04 | — | — | US | disclosed |
| US-20160095318-A1 | ANTIMICROBIAL COMPOSITION | Safehands Solutions, LLC | 2016-04-07 | — | — | US | disclosed |
| US-8546640-B2 | Infused sponge delivery system | EVRIHOLDER PRODUCTS, LLC (US) | 2013-10-01 | — | — | US | disclosed |
| US-20130236520-A1 | Infused Sponge Delivery System | SPONGEABLES, LLC (US) | 2013-09-12 | — | — | US | disclosed |
| US-20090285875-A1 | Infused Sponge Delivery System | EVRIHOLDER PRODUCTS, LLC | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090285875-A1 | Infused Sponge Delivery System | LIPC, CETP, CUTA | P2RY10 4352/4885GPR174 4648/4885LPAR3 3483/4885 |
| US-20170265476-A1 | ANTIMICROBIAL COMPOSITION | MGLL, PHOSPHO1, DEGS1 | P2RY10 252/4885GPR174 3658/4885LPAR3 481/4885 |
| US-20130236520-A1 | Infused Sponge Delivery System | LIPC, CETP, CUTA | P2RY10 4352/4885GPR174 4648/4885LPAR3 3483/4885 |
| US-20160095318-A1 | ANTIMICROBIAL COMPOSITION | MGLL, PHOSPHO1, DEGS1 | P2RY10 252/4885GPR174 3658/4885LPAR3 481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.